KORE, a company that specializes in internet of things (IoT) solutions, has unveiled its new Connected Health Telemetry Solution (CHTS) to enable remote patient monitoring, clinical drug trials, and medical equipment diagnostics.
“Orchestrating the data telemetry from patients, clinical trial participants, medical devices, and sensors is challenging,” says Bryan Lubel, KORE’s executive vice president of Connected Health. “Most connected health providers are forced to develop their own telemetry solution, when in fact, their real expertise is developing the analytics, workflow, care delivery optimization, and use of the data to improve patient care and outcomes. We believe this solution will accelerate the time-to-market and adoption of large-scale remote patient monitoring initiatives.”
According to the company, the telemetry solution was developed in response to the heightened demand for remote patient care and monitoring during the pandemic. Remote patient monitoring service providers, provider networks, clinical research organizations, and medical device original equipment manufacturers have been seeking ways to accelerate and scale their remote monitoring initiatives, KORE notes.
The telemetry solution is designed to provide integrated device management, secure Bluetooth low energy (BLE) pairing of medical sensors with a cellular gateway, and secure data routing to a compliant temporary data repository that integrates connected health data into customer applications. Companies can get help with hardware selection and validation, access to a robust suite of supported medical devices and sensors, BLE pairing and device management at scale, network security that addresses cybersecurity issues and data telemetry, as well as all regulatory and compliance controls.
In creating CHTS, KORE consulted with several healthcare and life sciences customers to address the common challenges and needs facing the industry. KORE’s customer Actigraph, a provider of medical-grade biometric monitoring technology, is currently in pilot with CHTS.
“The data telemetry component in healthcare and life sciences is complex, highly regulated, and difficult to scale,” says Jeremy Wyatt, CEO of Actigraph. “In addition, the current economics can be a barrier to market growth. KORE’s CHTS will improve our ability to focus on helping our customers make better informed clinical decisions and alleviate the burden of managing the complex data telemetry challenge.”
This week, KORE showcased a full demo of the Connected Health Telemetry Solution at the Mobile World Congress in Los Angeles. Additionally, KORE will host an Xtalks webinar on November 19 titled “Overcoming the Challenges of Implementing Connected Health Telemetry Initiatives.”
For more information, visit www.korewireless.com.
Featured Image: The Connected Health Telemetry Solution from KORE was developed in response to the heightened demand for remote patient care and monitoring during the pandemic. Photo: KORE.
